Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Terns Pharmaceuticals (TERN) Other Non Operating Income (2020 - 2022)

Terns Pharmaceuticals' Other Non Operating Income history spans 3 years, with the latest figure at -$4000.0 for Q4 2022.

  • For Q4 2022, Other Non Operating Income fell 140.0% year-over-year to -$4000.0; the TTM value through Dec 2022 reached -$68000.0, down 270.0%, while the annual FY2025 figure was -$93000.0, 745.45% down from the prior year.
  • Other Non Operating Income reached -$4000.0 in Q4 2022 per TERN's latest filing, up from -$14000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $250000.0 in Q2 2020 to a low of -$387000.0 in Q3 2020.
  • Average Other Non Operating Income over 3 years is $5916.7, with a median of $4000.0 recorded in 2021.
  • The largest YoY upside for Other Non Operating Income was 130.77% in 2022 against a maximum downside of 450.0% in 2022.
  • A 3-year view of Other Non Operating Income shows it stood at $69000.0 in 2020, then tumbled by 85.51% to $10000.0 in 2021, then crashed by 140.0% to -$4000.0 in 2022.
  • Per Business Quant, the three most recent readings for TERN's Other Non Operating Income are -$4000.0 (Q4 2022), -$14000.0 (Q3 2022), and -$54000.0 (Q2 2022).